The global market for Pharmaceutical Grade Captopril was valued at US$ 950 million in the year 2024 and is projected to reach a revised size of US$ 2207 million by 2031, growing at a CAGR of 12.8% during the forecast period.

Pharmaceutical Grade Captopril Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Pharmaceutical Grade Captopril competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.

In 2024, global Pharmaceutical Grade Captopril production reached approximately 11,795 tons, with an average global market price of around US$ 78 per kg.

The gross profit margin of major companies in the industry is between 28% – 42%.

Single-line production capacity is 1,800 – 3,500 tons/year.

Pharmaceutical grade captopril is an active pharmaceutical ingredient (API) used in ACE inhibitor medications for treating hypertension and heart failure. It must meet strict pharmacopeial purity standards and be produced under GMP-compliant conditions to ensure safety and efficacy.

North American market for Pharmaceutical Grade Captopril is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Pharmaceutical Grade Captopril is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Pharmaceutical Grade Captopril include Teva API, Cipla, Hetero Labs, Aurobindo Pharma, Zhejiang Huahai Pharmaceutical, Qilu Pharmaceutical, Jiangsu Hengrui, Zhejiang Hisun Pharmaceutical, Shandong Xinhua, Wanbang Biopharma, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Pharmaceutical Grade Captopril, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmaceutical Grade Captopril.

The Pharmaceutical Grade Captopril market size, estimations, and forecasts are provided in terms of sales volume (Tons) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pharmaceutical Grade Captopril market comprehensively. Regional market sizes, concerning products by Type, by Application, by Production Technology and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Pharmaceutical Grade Captopril manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, by Production Technology and by regions.

Scope of Pharmaceutical Grade Captopril Market Report

Report Metric	Details
Report Name	Pharmaceutical Grade Captopril Market
Accounted market size in year	US$ 950 million
Forecasted market size in 2031	US$ 2207 million
CAGR	12.8%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	USP-Grade Captopril EP-Grade Captopril Customized High-Purity Captopril
Segment by Production Technology	Chemical Synthesis Captopril Enzymatic Synthesis Captopril Continuous Production Captopril
Segment by Application	Hypertension (High Blood Pressure) Heart Failure Diabetic Nephropathy Post-Myocardial Infarction Management Others
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Teva API, Cipla, Hetero Labs, Aurobindo Pharma, Zhejiang Huahai Pharmaceutical, Qilu Pharmaceutical, Jiangsu Hengrui, Zhejiang Hisun Pharmaceutical, Shandong Xinhua, Wanbang Biopharma
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Pharmaceutical Grade Captopril manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Pharmaceutical Grade Captopril in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Pharmaceutical Grade Captopril Market growing?

Ans: The Pharmaceutical Grade Captopril Market witnessing a CAGR of 12.8% during the forecast period 2025-2031.

What is the Pharmaceutical Grade Captopril Market size in 2031?

Ans: The Pharmaceutical Grade Captopril Market size in 2031 will be US$ 2207 million.

Who are the main players in the Pharmaceutical Grade Captopril Market report?

Ans: The main players in the Pharmaceutical Grade Captopril Market are Teva API, Cipla, Hetero Labs, Aurobindo Pharma, Zhejiang Huahai Pharmaceutical, Qilu Pharmaceutical, Jiangsu Hengrui, Zhejiang Hisun Pharmaceutical, Shandong Xinhua, Wanbang Biopharma

What are the Application segmentation covered in the Pharmaceutical Grade Captopril Market report?

Ans: The Applications covered in the Pharmaceutical Grade Captopril Market report are Hypertension (High Blood Pressure), Heart Failure, Diabetic Nephropathy, Post-Myocardial Infarction Management, Others

What are the Type segmentation covered in the Pharmaceutical Grade Captopril Market report?

Ans: The Types covered in the Pharmaceutical Grade Captopril Market report are USP-Grade Captopril, EP-Grade Captopril, Customized High-Purity Captopril

1 Pharmaceutical Grade Captopril Market Overview

1.1 Product Definition

1.2 Pharmaceutical Grade Captopril by Type

1.2.1 Global Pharmaceutical Grade Captopril Market Value Comparison by Type (2024 VS 2031)

1.2.2 USP-Grade Captopril

1.2.3 EP-Grade Captopril

1.2.4 Customized High-Purity Captopril

1.3 Pharmaceutical Grade Captopril by Production Technology

1.3.1 Global Pharmaceutical Grade Captopril Market Value Comparison by Production Technology: 2024 VS 2031

1.3.2 Chemical Synthesis Captopril

1.3.3 Enzymatic Synthesis Captopril

1.3.4 Continuous Production Captopril

1.4 Pharmaceutical Grade Captopril by Application

1.4.1 Global Pharmaceutical Grade Captopril Market Value by Application (2024 VS 2031)

1.4.2 Hypertension (High Blood Pressure)

1.4.3 Heart Failure

1.4.4 Diabetic Nephropathy

1.4.5 Post-Myocardial Infarction Management

1.4.6 Others

1.5 Global Pharmaceutical Grade Captopril Market Size Estimates and Forecasts

1.5.1 Global Pharmaceutical Grade Captopril Revenue 2020-2031

1.5.2 Global Pharmaceutical Grade Captopril Sales 2020-2031

1.5.3 Global Pharmaceutical Grade Captopril Market Average Price (2020-2031)

1.6 Assumptions and Limitations

2 Pharmaceutical Grade Captopril Market Competition by Manufacturers

2.1 Global Pharmaceutical Grade Captopril Sales Market Share by Manufacturers (2020-2025)

2.2 Global Pharmaceutical Grade Captopril Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Pharmaceutical Grade Captopril Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Pharmaceutical Grade Captopril, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Pharmaceutical Grade Captopril, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Pharmaceutical Grade Captopril, Product Type & Application

2.7 Global Key Manufacturers of Pharmaceutical Grade Captopril, Date of Enter into This Industry

2.8 Global Pharmaceutical Grade Captopril Market Competitive Situation and Trends

2.8.1 Global Pharmaceutical Grade Captopril Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Pharmaceutical Grade Captopril Players Market Share by Revenue

2.8.3 Global Pharmaceutical Grade Captopril Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Pharmaceutical Grade Captopril Market Scenario by Region

3.1 Global Pharmaceutical Grade Captopril Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Pharmaceutical Grade Captopril Sales by Region: 2020-2031

3.2.1 Global Pharmaceutical Grade Captopril Sales by Region: 2020-2025

3.2.2 Global Pharmaceutical Grade Captopril Sales by Region: 2026-2031

3.3 Global Pharmaceutical Grade Captopril Revenue by Region: 2020-2031

3.3.1 Global Pharmaceutical Grade Captopril Revenue by Region: 2020-2025

3.3.2 Global Pharmaceutical Grade Captopril Revenue by Region: 2026-2031

3.4 North America Pharmaceutical Grade Captopril Market Facts & Figures by Country

3.4.1 North America Pharmaceutical Grade Captopril Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Pharmaceutical Grade Captopril Sales by Country (2020-2031)

3.4.3 North America Pharmaceutical Grade Captopril Revenue by Country (2020-2031)

3.4.4 United States

3.4.5 Canada

3.5 Europe Pharmaceutical Grade Captopril Market Facts & Figures by Country

3.5.1 Europe Pharmaceutical Grade Captopril Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Pharmaceutical Grade Captopril Sales by Country (2020-2031)

3.5.3 Europe Pharmaceutical Grade Captopril Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Pharmaceutical Grade Captopril Market Facts & Figures by Region

3.6.1 Asia Pacific Pharmaceutical Grade Captopril Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Pharmaceutical Grade Captopril Sales by Region (2020-2031)

3.6.3 Asia Pacific Pharmaceutical Grade Captopril Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Pharmaceutical Grade Captopril Market Facts & Figures by Country

3.7.1 Latin America Pharmaceutical Grade Captopril Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Pharmaceutical Grade Captopril Sales by Country (2020-2031)

3.7.3 Latin America Pharmaceutical Grade Captopril Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa Pharmaceutical Grade Captopril Market Facts & Figures by Country

3.8.1 Middle East and Africa Pharmaceutical Grade Captopril Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Pharmaceutical Grade Captopril Sales by Country (2020-2031)

3.8.3 Middle East and Africa Pharmaceutical Grade Captopril Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Pharmaceutical Grade Captopril Sales by Type (2020-2031)

4.1.1 Global Pharmaceutical Grade Captopril Sales by Type (2020-2025)

4.1.2 Global Pharmaceutical Grade Captopril Sales by Type (2026-2031)

4.1.3 Global Pharmaceutical Grade Captopril Sales Market Share by Type (2020-2031)

4.2 Global Pharmaceutical Grade Captopril Revenue by Type (2020-2031)

4.2.1 Global Pharmaceutical Grade Captopril Revenue by Type (2020-2025)

4.2.2 Global Pharmaceutical Grade Captopril Revenue by Type (2026-2031)

4.2.3 Global Pharmaceutical Grade Captopril Revenue Market Share by Type (2020-2031)

4.3 Global Pharmaceutical Grade Captopril Price by Type (2020-2031)

5 Segment by Application

5.1 Global Pharmaceutical Grade Captopril Sales by Application (2020-2031)

5.1.1 Global Pharmaceutical Grade Captopril Sales by Application (2020-2025)

5.1.2 Global Pharmaceutical Grade Captopril Sales by Application (2026-2031)

5.1.3 Global Pharmaceutical Grade Captopril Sales Market Share by Application (2020-2031)

5.2 Global Pharmaceutical Grade Captopril Revenue by Application (2020-2031)

5.2.1 Global Pharmaceutical Grade Captopril Revenue by Application (2020-2025)

5.2.2 Global Pharmaceutical Grade Captopril Revenue by Application (2026-2031)

5.2.3 Global Pharmaceutical Grade Captopril Revenue Market Share by Application (2020-2031)

5.3 Global Pharmaceutical Grade Captopril Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Teva API

6.1.1 Teva API Company Information

6.1.2 Teva API Description and Business Overview

6.1.3 Teva API Pharmaceutical Grade Captopril Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Teva API Pharmaceutical Grade Captopril Product Portfolio

6.1.5 Teva API Recent Developments/Updates

6.2 Cipla

6.2.1 Cipla Company Information

6.2.2 Cipla Description and Business Overview

6.2.3 Cipla Pharmaceutical Grade Captopril Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Cipla Pharmaceutical Grade Captopril Product Portfolio

6.2.5 Cipla Recent Developments/Updates

6.3 Hetero Labs

6.3.1 Hetero Labs Company Information

6.3.2 Hetero Labs Description and Business Overview

6.3.3 Hetero Labs Pharmaceutical Grade Captopril Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Hetero Labs Pharmaceutical Grade Captopril Product Portfolio

6.3.5 Hetero Labs Recent Developments/Updates

6.4 Aurobindo Pharma

6.4.1 Aurobindo Pharma Company Information

6.4.2 Aurobindo Pharma Description and Business Overview

6.4.3 Aurobindo Pharma Pharmaceutical Grade Captopril Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Aurobindo Pharma Pharmaceutical Grade Captopril Product Portfolio

6.4.5 Aurobindo Pharma Recent Developments/Updates

6.5 Zhejiang Huahai Pharmaceutical

6.5.1 Zhejiang Huahai Pharmaceutical Company Information

6.5.2 Zhejiang Huahai Pharmaceutical Description and Business Overview

6.5.3 Zhejiang Huahai Pharmaceutical Pharmaceutical Grade Captopril Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Zhejiang Huahai Pharmaceutical Pharmaceutical Grade Captopril Product Portfolio

6.5.5 Zhejiang Huahai Pharmaceutical Recent Developments/Updates

6.6 Qilu Pharmaceutical

6.6.1 Qilu Pharmaceutical Company Information

6.6.2 Qilu Pharmaceutical Description and Business Overview

6.6.3 Qilu Pharmaceutical Pharmaceutical Grade Captopril Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Qilu Pharmaceutical Pharmaceutical Grade Captopril Product Portfolio

6.6.5 Qilu Pharmaceutical Recent Developments/Updates

6.7 Jiangsu Hengrui

6.7.1 Jiangsu Hengrui Company Information

6.7.2 Jiangsu Hengrui Description and Business Overview

6.7.3 Jiangsu Hengrui Pharmaceutical Grade Captopril Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Jiangsu Hengrui Pharmaceutical Grade Captopril Product Portfolio

6.7.5 Jiangsu Hengrui Recent Developments/Updates

6.8 Zhejiang Hisun Pharmaceutical

6.8.1 Zhejiang Hisun Pharmaceutical Company Information

6.8.2 Zhejiang Hisun Pharmaceutical Description and Business Overview

6.8.3 Zhejiang Hisun Pharmaceutical Pharmaceutical Grade Captopril Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Zhejiang Hisun Pharmaceutical Pharmaceutical Grade Captopril Product Portfolio

6.8.5 Zhejiang Hisun Pharmaceutical Recent Developments/Updates

6.9 Shandong Xinhua

6.9.1 Shandong Xinhua Company Information

6.9.2 Shandong Xinhua Description and Business Overview

6.9.3 Shandong Xinhua Pharmaceutical Grade Captopril Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Shandong Xinhua Pharmaceutical Grade Captopril Product Portfolio

6.9.5 Shandong Xinhua Recent Developments/Updates

6.10 Wanbang Biopharma

6.10.1 Wanbang Biopharma Company Information

6.10.2 Wanbang Biopharma Description and Business Overview

6.10.3 Wanbang Biopharma Pharmaceutical Grade Captopril Sales, Revenue and Gross Margin (2020-2025)

6.10.4 Wanbang Biopharma Pharmaceutical Grade Captopril Product Portfolio

6.10.5 Wanbang Biopharma Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Pharmaceutical Grade Captopril Industry Chain Analysis

7.2 Pharmaceutical Grade Captopril Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Pharmaceutical Grade Captopril Production Mode & Process Analysis

7.4 Pharmaceutical Grade Captopril Sales and Marketing

7.4.1 Pharmaceutical Grade Captopril Sales Channels

7.4.2 Pharmaceutical Grade Captopril Distributors

7.5 Pharmaceutical Grade Captopril Customer Analysis

8 Pharmaceutical Grade Captopril Market Dynamics

8.1 Pharmaceutical Grade Captopril Industry Trends

8.2 Pharmaceutical Grade Captopril Market Drivers

8.3 Pharmaceutical Grade Captopril Market Challenges

8.4 Pharmaceutical Grade Captopril Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Zhejiang Huahai Pharmaceutical

Qilu Pharmaceutical

Jiangsu Hengrui

Zhejiang Hisun Pharmaceutical

Shandong Xinhua

Wanbang Biopharma

List of Tables

Table 1. Global Pharmaceutical Grade Captopril Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Pharmaceutical Grade Captopril Market Value by Production Technology, (US$ Million) & (2024 VS 2031)

Table 3. Global Pharmaceutical Grade Captopril Market Value by Application (2024 VS 2031) & (US$ Million)

Table 4. Global Pharmaceutical Grade Captopril Market Competitive Situation by Manufacturers in 2024

Table 5. Global Pharmaceutical Grade Captopril Sales (Tons) of Key Manufacturers (2020-2025)

Table 6. Global Pharmaceutical Grade Captopril Sales Market Share by Manufacturers (2020-2025)

Table 7. Global Pharmaceutical Grade Captopril Revenue (US$ Million) by Manufacturers (2020-2025)

Table 8. Global Pharmaceutical Grade Captopril Revenue Share by Manufacturers (2020-2025)

Table 9. Global Market Pharmaceutical Grade Captopril Average Price (US$/Ton) of Key Manufacturers (2020-2025)

Table 10. Global Key Players of Pharmaceutical Grade Captopril, Industry Ranking, 2022 VS 2023 VS 2024

Table 11. Global Key Manufacturers of Pharmaceutical Grade Captopril, Manufacturing Sites & Headquarters

Table 12. Global Key Manufacturers of Pharmaceutical Grade Captopril, Product Type & Application

Table 13. Global Key Manufacturers of Pharmaceutical Grade Captopril, Date of Enter into This Industry

Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 15. Global Pharmaceutical Grade Captopril by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical Grade Captopril as of 2024)

Table 16. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 17. Global Pharmaceutical Grade Captopril Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 18. Global Pharmaceutical Grade Captopril Sales by Region (2020-2025) & (Tons)

Table 19. Global Pharmaceutical Grade Captopril Sales Market Share by Region (2020-2025)

Table 20. Global Pharmaceutical Grade Captopril Sales by Region (2026-2031) & (Tons)

Table 21. Global Pharmaceutical Grade Captopril Sales Market Share by Region (2026-2031)

Table 22. Global Pharmaceutical Grade Captopril Revenue by Region (2020-2025) & (US$ Million)

Table 23. Global Pharmaceutical Grade Captopril Revenue Market Share by Region (2020-2025)

Table 24. Global Pharmaceutical Grade Captopril Revenue by Region (2026-2031) & (US$ Million)

Table 25. Global Pharmaceutical Grade Captopril Revenue Market Share by Region (2026-2031)

Table 26. North America Pharmaceutical Grade Captopril Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 27. North America Pharmaceutical Grade Captopril Sales by Country (2020-2025) & (Tons)

Table 28. North America Pharmaceutical Grade Captopril Sales by Country (2026-2031) & (Tons)

Table 29. North America Pharmaceutical Grade Captopril Revenue by Country (2020-2025) & (US$ Million)

Table 30. North America Pharmaceutical Grade Captopril Revenue by Country (2026-2031) & (US$ Million)

Table 31. Europe Pharmaceutical Grade Captopril Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 32. Europe Pharmaceutical Grade Captopril Sales by Country (2020-2025) & (Tons)

Table 33. Europe Pharmaceutical Grade Captopril Sales by Country (2026-2031) & (Tons)

Table 34. Europe Pharmaceutical Grade Captopril Revenue by Country (2020-2025) & (US$ Million)

Table 35. Europe Pharmaceutical Grade Captopril Revenue by Country (2026-2031) & (US$ Million)

Table 36. Asia Pacific Pharmaceutical Grade Captopril Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 37. Asia Pacific Pharmaceutical Grade Captopril Sales by Region (2020-2025) & (Tons)

Table 38. Asia Pacific Pharmaceutical Grade Captopril Sales by Region (2026-2031) & (Tons)

Table 39. Asia Pacific Pharmaceutical Grade Captopril Revenue by Region (2020-2025) & (US$ Million)

Table 40. Asia Pacific Pharmaceutical Grade Captopril Revenue by Region (2026-2031) & (US$ Million)

Table 41. Latin America Pharmaceutical Grade Captopril Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 42. Latin America Pharmaceutical Grade Captopril Sales by Country (2020-2025) & (Tons)

Table 43. Latin America Pharmaceutical Grade Captopril Sales by Country (2026-2031) & (Tons)

Table 44. Latin America Pharmaceutical Grade Captopril Revenue by Country (2020-2025) & (US$ Million)

Table 45. Latin America Pharmaceutical Grade Captopril Revenue by Country (2026-2031) & (US$ Million)

Table 46. Middle East and Africa Pharmaceutical Grade Captopril Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 47. Middle East and Africa Pharmaceutical Grade Captopril Sales by Country (2020-2025) & (Tons)

Table 48. Middle East and Africa Pharmaceutical Grade Captopril Sales by Country (2026-2031) & (Tons)

Table 49. Middle East and Africa Pharmaceutical Grade Captopril Revenue by Country (2020-2025) & (US$ Million)

Table 50. Middle East and Africa Pharmaceutical Grade Captopril Revenue by Country (2026-2031) & (US$ Million)

Table 51. Global Pharmaceutical Grade Captopril Sales (Tons) by Type (2020-2025)

Table 52. Global Pharmaceutical Grade Captopril Sales (Tons) by Type (2026-2031)

Table 53. Global Pharmaceutical Grade Captopril Sales Market Share by Type (2020-2025)

Table 54. Global Pharmaceutical Grade Captopril Sales Market Share by Type (2026-2031)

Table 55. Global Pharmaceutical Grade Captopril Revenue (US$ Million) by Type (2020-2025)

Table 56. Global Pharmaceutical Grade Captopril Revenue (US$ Million) by Type (2026-2031)

Table 57. Global Pharmaceutical Grade Captopril Revenue Market Share by Type (2020-2025)

Table 58. Global Pharmaceutical Grade Captopril Revenue Market Share by Type (2026-2031)

Table 59. Global Pharmaceutical Grade Captopril Price (US$/Ton) by Type (2020-2025)

Table 60. Global Pharmaceutical Grade Captopril Price (US$/Ton) by Type (2026-2031)

Table 61. Global Pharmaceutical Grade Captopril Sales (Tons) by Application (2020-2025)

Table 62. Global Pharmaceutical Grade Captopril Sales (Tons) by Application (2026-2031)

Table 63. Global Pharmaceutical Grade Captopril Sales Market Share by Application (2020-2025)

Table 64. Global Pharmaceutical Grade Captopril Sales Market Share by Application (2026-2031)

Table 65. Global Pharmaceutical Grade Captopril Revenue (US$ Million) by Application (2020-2025)

Table 66. Global Pharmaceutical Grade Captopril Revenue (US$ Million) by Application (2026-2031)

Table 67. Global Pharmaceutical Grade Captopril Revenue Market Share by Application (2020-2025)

Table 68. Global Pharmaceutical Grade Captopril Revenue Market Share by Application (2026-2031)

Table 69. Global Pharmaceutical Grade Captopril Price (US$/Ton) by Application (2020-2025)

Table 70. Global Pharmaceutical Grade Captopril Price (US$/Ton) by Application (2026-2031)

Table 71. Teva API Company Information

Table 72. Teva API Description and Business Overview

Table 73. Teva API Pharmaceutical Grade Captopril Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 74. Teva API Pharmaceutical Grade Captopril Product

Table 75. Teva API Recent Developments/Updates

Table 76. Cipla Company Information

Table 77. Cipla Description and Business Overview

Table 78. Cipla Pharmaceutical Grade Captopril Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 79. Cipla Pharmaceutical Grade Captopril Product

Table 80. Cipla Recent Developments/Updates

Table 81. Hetero Labs Company Information

Table 82. Hetero Labs Description and Business Overview

Table 83. Hetero Labs Pharmaceutical Grade Captopril Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 84. Hetero Labs Pharmaceutical Grade Captopril Product

Table 85. Hetero Labs Recent Developments/Updates

Table 86. Aurobindo Pharma Company Information

Table 87. Aurobindo Pharma Description and Business Overview

Table 88. Aurobindo Pharma Pharmaceutical Grade Captopril Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 89. Aurobindo Pharma Pharmaceutical Grade Captopril Product

Table 90. Aurobindo Pharma Recent Developments/Updates

Table 91. Zhejiang Huahai Pharmaceutical Company Information

Table 92. Zhejiang Huahai Pharmaceutical Description and Business Overview

Table 93. Zhejiang Huahai Pharmaceutical Pharmaceutical Grade Captopril Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 94. Zhejiang Huahai Pharmaceutical Pharmaceutical Grade Captopril Product

Table 95. Zhejiang Huahai Pharmaceutical Recent Developments/Updates

Table 96. Qilu Pharmaceutical Company Information

Table 97. Qilu Pharmaceutical Description and Business Overview

Table 98. Qilu Pharmaceutical Pharmaceutical Grade Captopril Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 99. Qilu Pharmaceutical Pharmaceutical Grade Captopril Product

Table 100. Qilu Pharmaceutical Recent Developments/Updates

Table 101. Jiangsu Hengrui Company Information

Table 102. Jiangsu Hengrui Description and Business Overview

Table 103. Jiangsu Hengrui Pharmaceutical Grade Captopril Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 104. Jiangsu Hengrui Pharmaceutical Grade Captopril Product

Table 105. Jiangsu Hengrui Recent Developments/Updates

Table 106. Zhejiang Hisun Pharmaceutical Company Information

Table 107. Zhejiang Hisun Pharmaceutical Description and Business Overview

Table 108. Zhejiang Hisun Pharmaceutical Pharmaceutical Grade Captopril Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 109. Zhejiang Hisun Pharmaceutical Pharmaceutical Grade Captopril Product

Table 110. Zhejiang Hisun Pharmaceutical Recent Developments/Updates

Table 111. Shandong Xinhua Company Information

Table 112. Shandong Xinhua Description and Business Overview

Table 113. Shandong Xinhua Pharmaceutical Grade Captopril Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 114. Shandong Xinhua Pharmaceutical Grade Captopril Product

Table 115. Shandong Xinhua Recent Developments/Updates

Table 116. Wanbang Biopharma Company Information

Table 117. Wanbang Biopharma Description and Business Overview

Table 118. Wanbang Biopharma Pharmaceutical Grade Captopril Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 119. Wanbang Biopharma Pharmaceutical Grade Captopril Product

Table 120. Wanbang Biopharma Recent Developments/Updates

Table 121. Key Raw Materials Lists

Table 122. Raw Materials Key Suppliers Lists

Table 123. Pharmaceutical Grade Captopril Distributors List

Table 124. Pharmaceutical Grade Captopril Customers List

Table 125. Pharmaceutical Grade Captopril Market Trends

Table 126. Pharmaceutical Grade Captopril Market Drivers

Table 127. Pharmaceutical Grade Captopril Market Challenges

Table 128. Pharmaceutical Grade Captopril Market Restraints

Table 129. Research Programs/Design for This Report

Table 130. Key Data Information from Secondary Sources

Table 131. Key Data Information from Primary Sources

Table 132. Authors List of This Report

List of Figures

Figure 1. Product Picture of Pharmaceutical Grade Captopril

Figure 2. Global Pharmaceutical Grade Captopril Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Pharmaceutical Grade Captopril Market Share by Type: 2024 & 2031

Figure 4. USP-Grade Captopril Product Picture

Figure 5. EP-Grade Captopril Product Picture

Figure 6. Customized High-Purity Captopril Product Picture

Figure 7. Global Pharmaceutical Grade Captopril Market Value by Production Technology, (US$ Million) & (2020-2031)

Figure 8. Global Pharmaceutical Grade Captopril Market Share by Production Technology: 2024 VS 2031

Figure 9. Chemical Synthesis Captopril Product Picture

Figure 10. Enzymatic Synthesis Captopril Product Picture

Figure 11. Continuous Production Captopril Product Picture

Figure 12. Global Pharmaceutical Grade Captopril Market Value by Application (2020-2031) & (US$ Million)

Figure 13. Global Pharmaceutical Grade Captopril Market Share by Application: 2024 & 2031

Figure 14. Hypertension (High Blood Pressure)

Figure 15. Heart Failure

Figure 16. Diabetic Nephropathy

Figure 17. Post-Myocardial Infarction Management

Figure 18. Others

Figure 19. Global Pharmaceutical Grade Captopril Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 20. Global Pharmaceutical Grade Captopril Market Size (2020-2031) & (US$ Million)

Figure 21. Global Pharmaceutical Grade Captopril Sales (2020-2031) & (Tons)

Figure 22. Global Pharmaceutical Grade Captopril Average Price (US$/Ton) & (2020-2031)

Figure 23. Pharmaceutical Grade Captopril Report Years Considered

Figure 24. Pharmaceutical Grade Captopril Sales Share by Manufacturers in 2024

Figure 25. Global Pharmaceutical Grade Captopril Revenue Share by Manufacturers in 2024

Figure 26. Global 5 and 10 Largest Pharmaceutical Grade Captopril Players: Market Share by Revenue in Pharmaceutical Grade Captopril in 2024

Figure 27. Pharmaceutical Grade Captopril Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 28. Global Pharmaceutical Grade Captopril Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 29. North America Pharmaceutical Grade Captopril Sales Market Share by Country (2020-2031)

Figure 30. North America Pharmaceutical Grade Captopril Revenue Market Share by Country (2020-2031)

Figure 31. United States Pharmaceutical Grade Captopril Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Canada Pharmaceutical Grade Captopril Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. Europe Pharmaceutical Grade Captopril Sales Market Share by Country (2020-2031)

Figure 34. Europe Pharmaceutical Grade Captopril Revenue Market Share by Country (2020-2031)

Figure 35. Germany Pharmaceutical Grade Captopril Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. France Pharmaceutical Grade Captopril Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. U.K. Pharmaceutical Grade Captopril Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. Italy Pharmaceutical Grade Captopril Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. Russia Pharmaceutical Grade Captopril Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Asia Pacific Pharmaceutical Grade Captopril Sales Market Share by Region (2020-2031)

Figure 41. Asia Pacific Pharmaceutical Grade Captopril Revenue Market Share by Region (2020-2031)

Figure 42. China Pharmaceutical Grade Captopril Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Japan Pharmaceutical Grade Captopril Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. South Korea Pharmaceutical Grade Captopril Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. India Pharmaceutical Grade Captopril Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Australia Pharmaceutical Grade Captopril Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. China Taiwan Pharmaceutical Grade Captopril Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Southeast Asia Pharmaceutical Grade Captopril Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 49. Latin America Pharmaceutical Grade Captopril Sales Market Share by Country (2020-2031)

Figure 50. Latin America Pharmaceutical Grade Captopril Revenue Market Share by Country (2020-2031)

Figure 51. Mexico Pharmaceutical Grade Captopril Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. Brazil Pharmaceutical Grade Captopril Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. Argentina Pharmaceutical Grade Captopril Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 54. Colombia Pharmaceutical Grade Captopril Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 55. Middle East and Africa Pharmaceutical Grade Captopril Sales Market Share by Country (2020-2031)

Figure 56. Middle East and Africa Pharmaceutical Grade Captopril Revenue Market Share by Country (2020-2031)

Figure 57. Turkey Pharmaceutical Grade Captopril Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 58. Saudi Arabia Pharmaceutical Grade Captopril Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 59. UAE Pharmaceutical Grade Captopril Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 60. Global Sales Market Share of Pharmaceutical Grade Captopril by Type (2020-2031)

Figure 61. Global Revenue Market Share of Pharmaceutical Grade Captopril by Type (2020-2031)

Figure 62. Global Pharmaceutical Grade Captopril Price (US$/Ton) by Type (2020-2031)

Figure 63. Global Sales Market Share of Pharmaceutical Grade Captopril by Application (2020-2031)

Figure 64. Global Revenue Market Share of Pharmaceutical Grade Captopril by Application (2020-2031)

Figure 65. Global Pharmaceutical Grade Captopril Price (US$/Ton) by Application (2020-2031)

Figure 66. Pharmaceutical Grade Captopril Value Chain

Figure 67. Channels of Distribution (Direct Vs Distribution)

Figure 68. Bottom-up and Top-down Approaches for This Report

Figure 69. Data Triangulation

Figure 70. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global dATP Solution Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-4W20261

Sat Nov 22 00:00:00 UTC 2025

Add to Cart

Global Zebrafish Imaging Equipment Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-31F17056

Sat Nov 22 00:00:00 UTC 2025

Add to Cart

Global Regenerative Biologic Injectables Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-38V19822

Sat Nov 22 00:00:00 UTC 2025

Add to Cart

Global Image-guided Injectables Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-5A20092

Sat Nov 22 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions